Otsuka Pharmaceutical's Bronchodilator Meptin to Get New Dosage Form
Main Category: Public HealthArticle Date: 02 Sep 2004 - 15:00 PDT
'Otsuka Pharmaceutical's Bronchodilator Meptin to Get New Dosage Form'
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
3.33 (3 votes) |
Tokyo (JCNN) - Otsuka Pharmaceutical announced August 30 that it will release Meptin Dry Syrup 0.005%, a new dosage form in its Meptin series of bronchodilator, on September 7.
Provided in fine granule, the new product enables delicate dose adjustments according to patients' conditions. The sweet and easily-soluble product is useful for pediatric service.
With the new product launch, the Meptin series has nine dose forms available in total.
View Otsuka Pharmaceutical Co., Ltd. Company profile here.
Copyright © 2001-2004 JCNN. All rights reserved. A division of Japan Corporate News Network KK.
Visit our public health section for the latest news on this subject.
MLA
26 May. 2012. <http://www.medicalnewstoday.com/releases/12821.php>
APA
http://www.medicalnewstoday.com/releases/12821.php.
Please note: If no author information is provided, the source is cited instead.
Add Your Opinion On This Article
'Otsuka Pharmaceutical's Bronchodilator Meptin to Get New Dosage Form'Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.






